Christelle Clément-Duchêne1,2, Shannon Stock3, Xiangyan Xu4, Ellen T Chang5,6, Scarlett Lin Gomez5,7, Dee W West5,7, Heather A Wakelee1, Michael K Gould8. 1. 1 Department of Medicine, Stanford Cancer Institute, and. 2. 2 Respiratory Diseases Department, University Hospital, Vandoeuvre-lès-Nancy, France. 3. 3 Department of Mathematics and Computer Science, College of the Holy Cross, Worcester, Massachusetts. 4. 4 Palo Alto Institute for Research and Education, Palo Alto, California. 5. 5 Division of Epidemiology, Department of Health Research and Policy, School of Medicine, Stanford University, Stanford, California. 6. 6 Health Sciences Practice, Exponent, Inc., Menlo Park, California. 7. 7 Cancer Prevention Institute of California, Fremont, California; and. 8. 8 Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
Abstract
RATIONALE: Differences in patient characteristics and outcomes have been observed among current, former, and never-smokers with lung cancer, but most prior studies included few never-smokers and were not prospective. OBJECTIVES: We used data from a large, prospective study of lung cancer care and outcomes in the United States to compare characteristics of never-smokers and smokers with lung cancer and to examine survival among the never-smokers. METHODS: Smoking status at diagnosis was determined by self-report and survival was determined from medical records and cancer registries, with follow-up through June 2010 or later. Cox regression was used to examine the association between smoking and survival, and to identify predictors of survival among never-smokers. MEASUREMENTS AND MAIN RESULTS: Among 3,410 patients with lung cancer diagnosed between September 1, 2003 and October 14, 2005 who completed a baseline patient survey, there were 274 never-smokers (8%), 1,612 former smokers (47%), 1,496 current smokers or smokers who quit recently (44%), and 28 with missing information about smoking status (<1%). Never-smokers appeared more likely than former and current/recent smokers to be female and of Asian or Hispanic race/ethnicity, and to have adenocarcinoma histology, fewer comorbidities, private insurance, and higher income and education. Compared with never-smokers, the adjusted hazard of death from any cause was 29% higher among former smokers (hazard ratio, 1.29; 95% confidence interval, 1.08-1.55), and 39% higher among current/recent smokers (hazard ratio, 1.39; 95% confidence interval, 1.16-1.67). Factors predicting worse overall survival among never-smokers included Hispanic ethnicity, severe comorbidity, undifferentiated histology, and regional or distant stage. Never-smoking Hispanics appeared more likely to have regional or advanced disease at diagnosis and less likely to undergo surgical resection, although these differences were not statistically significant. CONCLUSIONS: Never-smokers with lung cancer are more likely than ever-smokers to be female, Asian or Hispanic, and more advantaged socioeconomically, suggesting possible etiologic differences in lung cancer by smoking status. Among never-smokers, Hispanics with lung cancer had worse survival than non-Hispanic whites.
RATIONALE: Differences in patient characteristics and outcomes have been observed among current, former, and never-smokers with lung cancer, but most prior studies included few never-smokers and were not prospective. OBJECTIVES: We used data from a large, prospective study of lung cancer care and outcomes in the United States to compare characteristics of never-smokers and smokers with lung cancer and to examine survival among the never-smokers. METHODS: Smoking status at diagnosis was determined by self-report and survival was determined from medical records and cancer registries, with follow-up through June 2010 or later. Cox regression was used to examine the association between smoking and survival, and to identify predictors of survival among never-smokers. MEASUREMENTS AND MAIN RESULTS: Among 3,410 patients with lung cancer diagnosed between September 1, 2003 and October 14, 2005 who completed a baseline patient survey, there were 274 never-smokers (8%), 1,612 former smokers (47%), 1,496 current smokers or smokers who quit recently (44%), and 28 with missing information about smoking status (<1%). Never-smokers appeared more likely than former and current/recent smokers to be female and of Asian or Hispanic race/ethnicity, and to have adenocarcinoma histology, fewer comorbidities, private insurance, and higher income and education. Compared with never-smokers, the adjusted hazard of death from any cause was 29% higher among former smokers (hazard ratio, 1.29; 95% confidence interval, 1.08-1.55), and 39% higher among current/recent smokers (hazard ratio, 1.39; 95% confidence interval, 1.16-1.67). Factors predicting worse overall survival among never-smokers included Hispanic ethnicity, severe comorbidity, undifferentiated histology, and regional or distant stage. Never-smoking Hispanics appeared more likely to have regional or advanced disease at diagnosis and less likely to undergo surgical resection, although these differences were not statistically significant. CONCLUSIONS: Never-smokers with lung cancer are more likely than ever-smokers to be female, Asian or Hispanic, and more advantaged socioeconomically, suggesting possible etiologic differences in lung cancer by smoking status. Among never-smokers, Hispanics with lung cancer had worse survival than non-Hispanic whites.
Entities:
Keywords:
Asian ethnicity; Hispanic ethnicity; cigarette smoking; lung cancer; survival
Authors: Scarlett L Gomez; Ellen T Chang; Sarah J Shema; Kari Fish; Jennette D Sison; Peggy Reynolds; Christelle Clément-Duchêne; Margaret R Wrensch; John L Wiencke; Heather A Wakelee Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-01-14 Impact factor: 4.254
Authors: Heather A Wakelee; Ellen T Chang; Scarlett L Gomez; Theresa H Keegan; Diane Feskanich; Christina A Clarke; Lars Holmberg; Lee C Yong; Laurence N Kolonel; Michael K Gould; Dee W West Journal: J Clin Oncol Date: 2007-02-10 Impact factor: 44.544
Authors: Philip C Mack; Michael I Klein; Kristin L Ayers; Xiang Zhou; Sunny Guin; Marc Fink; Michael Rossi; Hussam Ai-Kateb; Timmy O'Connell; Feras M Hantash; William K Oh; Scott Newman; Eric E Schadt; Rong Chen; Fred R Hirsch Journal: Oncologist Date: 2022-06-08 Impact factor: 5.837
Authors: Talita Helena Araujo de Oliveira; Carolina Medeiros do Amaral; Bianca de França São Marcos; Kamylla Conceição Gomes Nascimento; Ana Carine de Miranda Rios; Dafne Carolina Alves Quixabeira; Maria Tereza Cartaxo Muniz; Jacinto da Costa Silva Neto; Antonio Carlos de Freitas Journal: J Cancer Res Clin Oncol Date: 2018-09-17 Impact factor: 4.553
Authors: Aimee Jones; Lana J Mitchell; Rochelle O'Connor; Megan E Rollo; Katherine Slater; Lauren T Williams; Lauren Ball Journal: J Med Internet Res Date: 2018-10-15 Impact factor: 5.428